Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes

Obstetrics and Gynecology

Volumn 87, Issue 1, 1996, Pages 69-73

  Scott, L Laurie ^a   Sanchez, Pablo J ^a   Jackson, Gregory L ^a   Zeray, Fiker ^a   Wendel Jr , George D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; NEWBORN INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; VAGINAL DELIVERY; VIRUS CULTURE; VIRUS SHEDDING;

EID: 0030025092     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00357-6     Document Type: Article

References (20)

1. Prober CG, Corey L, Brown ZA, et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992;15:1031-8.
2. American College of Obstetricians and Gynecologists. Perinatal herpes simplex virus infections. ACOG technical bulletin no. 122. Washington, DC: American College of Obstetricians and Gynecologists, 1988.
3. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. JAMA 1993;270: 77-82.
4. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir. Arch Dermatol 1993; 129:582-7.
5. Stone KM, Whittington WL. Treatment of genital herpes. Rev Infect Dis 1990;12(S6):S610-9.
6. Frenkel LM, Brown ZA, Bryson YJ, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991;164:569-76.
7. Corey L, Spear PG. Infections with herpes simplex viruses (second of two parts). N Engl J Med 1986;314:749-58.
8. Hankins GDV, Cunningham FG, Luby JP, Butler SL, Stroud J, Roark M. Asymptomatic genital excretion of herpes simplex virus during early labor. Am J Obstet Gynecol 1984;150:100-1.
9. Brown ZA, Vontver LA, Benedetti J, et al. Genital herpes in pregnancy: Risk factors associated with recurrences and asymptomatic viral shedding. Am J Obstet Gynecol 1985;153:24-30.
10. Whitehead J. The design and analysis of sequential clinical trials. New York: John Wiley and Sons, 1983.
11. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. New Engl J Med 1979;301:1410-2.
12. Makuch R, Johnson M. Issues in planning and interpreting active control equivalence studies. J Clin Epidemiol 1989;42:503-11.
13. Brown ZA, Watts DH. Antiviral therapy in pregnancy. Clin Obstet Gynecol 1990;33:276-89.
14. Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800.
15. Wittek AE, Yeager AS, Au DS, Hensleigh PA. Asymptomatic shedding of herpes simplex virus from the cervix and lesion site during delivery. Am J Dis Child 1984;138:438-42.
16. Prober CG. Herpetic vaginitis in 1993. Clin Obstet Gynecol 1993; 36:177-87.
17. Centers for Disease Control and Prevention. Pregnancy outcomes following systemic prenatal acyclovir exposure - June 1, 1984-June 30, 1993. MMWR 1993;42:806-9.
18. Hintz M, Connor JD, Spector SA, Blum MR, Keeney RE, Yeager AS. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections. Am J Med 1982;73:210-4.
19. Yeager AS. Use of acyclovir in premature and term neonates. Am J Med 1982;73:205-9.
20. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Int Med 1994;121: 847-54.